Acute pharmacologic blockade of dyskinesias in Parkinson's Disease

Movement Disorders

Volumn 11, Issue 5, 1996, Pages 580-581

  Blanchet, Pierre J ^a   Metman, Leo Verhagen ^a   Mouradian, M Maral ^a   Chase, Thomas N ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; DEXTRORPHAN; LEVODOPA; NARCOTIC ANALGESIC AGENT;

ADULT; CASE REPORT; DYSKINESIA; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029816371     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110516     Document Type: Short Survey

References (9)

1. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
2. Wüllner U, Kupsch A, Arnold G, et al. The competitive NMDA antagonist CGP40.116 enhances L-DOPA response in MPTP-treated marmosets. Neuropharmacology 1992;31: 713-715.
3. Greenamyre JT, Eller RV, Zhang Z, Ovadia A, Kurlan R, Gash DM. Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann Neurol 1994;35:655-661.
4. Papa SM, Blanchet PJ, Linfante I, Chase TN. Suppression of levodopa-induced dyskinesias by an NMDA receptor antagonist in MPTP-treated monkeys. Neurology 1995;45: 1417.
5. Mouradian MM, Heuser IJE, Baronti F, Fabbrini G, Juncos JL, Chase TN. Pathogenesis of dyskinesias in Parkinson's disease. Ann Neurol 1989;25:523-526.
6. 2 balance in the basal ganglia and its relevance to Parkinson's disease. Synapse 1995;19:264-293.
7. Kelland MD Sr, Walters JR. Apomorphine-induced changes in striatal and pallidal neuronal activity are modified by NMDA and muscarinic receptor blockade. Life Sci 1992;50: PL179-PL184.
8. Filion M, Tremblay L, Bédard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:152-161.
9. Engber TM, Anderson JJ, Boldry RC, Papa SM, Kuo S, Chase TN. Excitatory amino acid receptor antagonists modify regional cerebral metabolic responses to levodopa in 6-hydroxydopamine-lesioned rats. Neuroscience 1994;59: 389-399.